Two marijuana dispensaries may come to Brooklyn as early as next year, aimed to improve access and affordability for qualifying patients
The New York State Department of Health announced earlier this month the authorization of five additional registered organizations (ROs) to manufacture and dispense medical marijuana in New York State, two of which plan to open marijuana dispensaries in Brooklyn. The authorization is part of an initiative aimed to improve access and affordability for qualifying patients.
“The New York State Department of Health is committed to growing the state’s Medical Marijuana Program responsibly,” said New York State Department of Health Commissioner Dr. Howard Zucker. “The addition of these registered organizations will make it easier for patients across the state to obtain medical marijuana, improve the affordability of medical marijuana products through the introduction of new competition and increase the variety of medical marijuana products available to patients.”
The newly authorized ROs are Citiva Medical, Fiorello Pharmaceuticals, New York Canna, PalliaTech NY and Valley Agriceuticals. They join the already operating five ROs MedMen, Columbia Care, Etain, PharmaCann and Vireo Health of New York. Citiva Medical Kings and Valley Agriceutical plan to open their dispensaries in Brooklyn.
Other recent enhancements to NY State’s medical marijuana program include adding chronic pain as a qualifying condition, permitting home delivery, empowering nurse practitioners and physician assistants to certify patients. Also, patients are being given access to new forms of medical marijuana, such as lozenges and lotions, in addition to the current options already available at dispensaries, THC cartridges, tinctures or capsules which are filled with coconut oil and cannabis extract.
The state first launched its medical marijuana program in January 2016. Since then, 25,736 certified patients and 1,139 registered practitioners have been participating in the program. Patients only have access to products that can’t be used recreationally. Integrating five additional registered organizations into the industry utilizing a phased-in approach was a recommendation of the Department’s two-year report on the Medical Use of Marijuana Under the Compassionate Care Act.